A hormone that reverses obesity in mice appears to work by signaling to a brain region involved in metabolism and appetite ...

Some GLP-1 receptor agonists, particularly semaglutide, reduced the risk for worsening mental health in people with anxiety ...

This innovative oral GLP-1 is a ‘small molecule’ medication that, unlike the Wegovy pill, doesn’t require that you take it on an empty stomach.

Yale researchers study GLP-1’s potential to reduce addiction and improve outcomes in substance use disorder patients, based on clinical and ...

The FDA approved a once-daily oral GLP-1 receptor agonist for adults with obesity or overweight with weight-related ...

There’s growing evidence that GLP-1 drugs can treat more than diabetes and obesity. “It was a surprise to people. Here’s an ...

More than 100,000 people die every year from opioid overdoses - and some believe the new class of drugs could help save those ...

The U.S. Food and Drug Administration (FDA) has approved a once-daily GLP-1 pill for weight loss called orforglipron, and ...

P.E.I. potato farmers are facing a new challenge as they get ready to plant their crop for 2026. Experts say the food ...

Tirzepatide vs. semaglutide, which is better? Medical experts agree that tirzepatide has better results, but the right drug ...

Weight-loss jabs will be given to 1.2 million people on the NHS to stop heart attacks and strokes. New guidance from the NHS ...

U.S. health officials have approved a new weight-loss pill from Eli Lilly. The Food and Drug Administration's decision ...